<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2883">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05497427</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00064230</org_study_id>
    <nct_id>NCT05497427</nct_id>
  </id_info>
  <brief_title>Normative Database and Test-Retest Reliability for BrainCheck Assessments</brief_title>
  <acronym>NDTR</acronym>
  <official_title>Normative Database and Test-Retest Reliability for BrainCheck Assessments</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BrainCheck, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>BrainCheck, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect normative test values and demographic information for&#xD;
      normative and referential data for a rapid, portable, computerized neurocognitive testing&#xD;
      device from healthy adults 50 and older.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BrainCheck's battery of 12 cognitive assessments will be used in this study, which aims to&#xD;
      measure a variety of cognitive domains (memory, attention, mental flexibility, executive&#xD;
      function, processing speed, balance, reasoning, visuospatial construction, language, and&#xD;
      visual hallucinations).&#xD;
&#xD;
      With the decline in cognition occurring at a quicker rate at older ages, this study aims to&#xD;
      collect additional data from healthy older adults to better capture the normative&#xD;
      distribution among these age groups from existing and new assessments.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 10, 2022</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mean, standard deviation, and percentiles of values of BrainCheck Assessments</measure>
    <time_frame>5 months</time_frame>
    <description>BrainCheck Assessment values will be calculated by descriptive statistics. Mean, standard deviation, and percentiles (1, 5, 10, 25, 50, 75, 90, 95, 99) of the scores will be calculated for each individual assessment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Test-retest reliability of BrainCheck Assessment values between two different time points</measure>
    <time_frame>5 months</time_frame>
    <description>Evaluate the test-retest reliability of BrainCheck assessments using Pearson Correlation coefficients on the descriptive statistics of each individual assessment.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Cognitive Change</condition>
  <condition>Cognitive Decline</condition>
  <condition>Cognitive Deterioration</condition>
  <condition>Neurocognitive Deficit</condition>
  <arm_group>
    <arm_group_label>Normative</arm_group_label>
    <description>BrainCheck assessment values from participants that have indications of healthy cognition at the time of testing ( a SLUMS result considered 'normal', more than 4 hours of sleep the night before, not having consumed alcohol or drugs within the last 6 hours, or not have participated in high capacity and strenuous physical activity within the last hour.)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test-Retest</arm_group_label>
    <description>Comparing BrainCheck assessment values between an initial visit test and a follow-up visit test 7-14 days later within subjects.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Per Protocol</arm_group_label>
    <description>BrainCheck assessment values from participants that completed all procedures with no protocol deviations</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BrainCheck Assessment</intervention_name>
    <description>A computerized neurocognitive test administered via an electronic device, such as a phone, tablet or computer, that contains several assessments that will aid in establishing an individuals cognitive performance</description>
    <arm_group_label>Normative</arm_group_label>
    <arm_group_label>Per Protocol</arm_group_label>
    <arm_group_label>Test-Retest</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will consist of healthy volunteers 50 years of age or older.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged 50 or older&#xD;
&#xD;
          -  Willing and able to comply with study requirements and activities&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Concerns with memory within the past 5 years&#xD;
&#xD;
          -  TBI within the last 6 months&#xD;
&#xD;
          -  Neurosurgery within the last month&#xD;
&#xD;
          -  Experienced a stroke&#xD;
&#xD;
          -  Self reported neurological condition (including mild neuropsychological impairment,&#xD;
             dementia, Parkinson's disease, amyotrophic lateral sclerosis, Multiple sclerosis, or&#xD;
             long-covid)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kevin Sun</last_name>
    <phone>281-616-5206</phone>
    <email>study@braincheck.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bin Huang, PhD</last_name>
    <phone>8323038175</phone>
    <email>bin@braincheck.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>BrainCheck</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78702</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Sun</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>BrainCheck</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77005</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Sun</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>BrainCheck</name>
      <address>
        <city>Mountlake Terrace</city>
        <state>Washington</state>
        <zip>98043</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Sun</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2022</verification_date>
  <study_first_submitted>August 5, 2022</study_first_submitted>
  <study_first_submitted_qc>August 9, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">August 11, 2022</study_first_posted>
  <last_update_submitted>October 12, 2022</last_update_submitted>
  <last_update_submitted_qc>October 12, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Healthy Volunteers</keyword>
  <keyword>Dementia</keyword>
  <keyword>Alzheimer's Disease</keyword>
  <keyword>Mild Cognitive Impairment</keyword>
  <keyword>Older Adults</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

